Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2023

28-02-2023 | Granulomatosis with Polyangiitis | Clinical Image

Ear Swelling of Relapsing Polychondritis

Authors: Nathan Charles Karp, MD, Sarah Elizabeth Goglin, MD

Published in: Journal of General Internal Medicine | Issue 9/2023

Login to get access

Excerpt

A 61-year-old man presented to rheumatology clinic for evaluation of subacute ear swelling and pain. Physical examination demonstrated edematous, tender pinnae with sparing of the earlobes bilaterally (Fig. 1 Panel A). He had a C-reactive protein of 109.7 (<8.1 mg/L) and a proteinase 3 antibody of 74 AU/mL (26 AU/mL or greater defined as positive). An audiogram demonstrated sensorineural hearing loss. A diagnosis of relapsing polychondritis (RPC) secondary to granulomatosis with polyangiitis (GPA) was made. Treatment with prednisone was initiated and on follow-up 8 weeks later, he had improvement in auricular inflammation (Fig. 1 Panel B). Rituximab was initiated for induction therapy of GPA.
Metadata
Title
Ear Swelling of Relapsing Polychondritis
Authors
Nathan Charles Karp, MD
Sarah Elizabeth Goglin, MD
Publication date
28-02-2023
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 9/2023
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-023-08097-4

Other articles of this Issue 9/2023

Journal of General Internal Medicine 9/2023 Go to the issue

Letter to the Editor

Response to Ojha and Lu

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine